Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CVT-124 enters phase II trials for CHF

April 16, 1997

Meiji Seika discloses new cardiotonic agents

April 16, 1997

Takeda reveals endothelin antagonists

April 14, 1997

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

Lederle (Japan) reports novel cardioprotective agents

April 10, 1997

SmithKline Beecham claims novel endothelin antagonists

April 9, 1997

AMBI's Cardia Salt Alternative associated with reduced blood pressure

April 9, 1997

Component of olive oil demonstrates antioxidant and lipoxygenase-inhibitory effects

April 8, 1997

Transmyocardial Revascularization phase II results reported

April 7, 1997

Yamanouchi characterizes new vasopressin antagonist, YM-087

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...